Institutionelle bei Millennium Pharma

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Citigroup Inc. 7,817,332 $110,146,207
Taunus Corporation 6,071,629 $85,549,252
Barclays Bank Plc 5,954,288 $83,895,917
FMR Corporation (Fidelity Management & Research Corp) 39,998,150 $563,573,933
Janus Capital Management, LLC 5,550,315 $78,203,938
Morgan Stanley 4,277,685 $60,272,581
State Street Corporation 3,633,374 $51,194,239
Dresdner Bank Ag 3,383,420 $47,672,387
JP Morgan Chase & Company 3,375,589 $47,562,049
AXA Financial, Inc. 2,851,485 $40,177,423

Topliste der investierten Fonds
Fidelity Growth Company Fund 13,149,477 $185,276,130
Fidelity Select Portfolios - Biotechnology 7,881,762 $111,054,026
Fidelity Aggressive Growth Fund 6,966,778 $98,161,902
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 4,697,460 $66,187,211
Janus Mercury Fund 3,151,895 $44,410,200
Smith Barney Aggressive Growth Fund Inc. 2,961,900 $41,733,171
Variable Insurance Products Fd-Growth Portfolio 2,555,380 $36,005,304
UBS (Lux) Biotech 2,081,028 $29,321,684
Finex Fonds Bio Spezial 1,777,140 $25,039,902
Fidelity Advisor Equity Growth Fund 1,753,400 $24,705,406